My watch list
my.chemeurope.com  
Login  

Safety monitoring



Safety Monitoring of a clinical trial is conducted by an independent physician with relevant expertise. This is accomplished by review of adverse event, immediately after they occur, with timely follow-up through resolution.

Additional recommended knowledge

Responsibility for data and safety monitoring depends on the phase of the study and may be conducted by sponsor or CRO staff or contractor, and/or by the Principal clinical investigator/project manager conducting the study. Regardless of the method used, monitoring must be performed on a regular basis. Oversight of the monitoring activity is the responsibility of the sponsor.

See also

References

  • Ariel E. Quinio, Safety in Clinical Trials: Who is Responsible?International Biopharmaceutical Association:IBPA Publications, 2005
  • Carol Rados, Inside Clinical Trials Testing Medical Products in People FDA Consumer magazine, September-October 2003 Issue


 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Safety_monitoring". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE